Experts Give AER Prep Course, Discuss Potential Potholes At UNPA Seminar
This article was originally published in The Tan Sheet
The implementation of the adverse event reporting bill will present the dietary supplement and nonprescription drug industries with challenges as well as opportunities, experts stressed at a recent United Natural Products Alliance seminar on the implementation of the new law
You may also be interested in...
Current MedWatch Form Stays While More Changes Could Occur Later In 2008
Substantive changes to FDA's MedWatch forms could come from the agency's MedWatch Plus program as soon as later this year
Return To Sender, Industry Groups Say Of AER Address Guidance
FDA's recommendation for complete addresses on OTC and dietary supplement product labels in order to comply with the adverse event reporting law exceeds not only Congress's intent, but also the requirements for all other products regulated by the agency, industry groups say
AHPA Asks FDA To Allow Firms To Route AER Contact To Offices Outside U.S.
FDA's guidance on adverse event reporting for OTC drugs and dietary supplements should assure that firms operating outside the country can use U.S. addresses on their product labels but receive AER-related communication in their home countries, the American Herbal Products Association recommends